用于分析鼻病毒蛋白酶抑制剂的简单体外翻译试验。
Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases.
作者信息
Heinz B A, Tang J, Labus J M, Chadwell F W, Kaldor S W, Hammond M
机构信息
Infectious Disease Research, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA.
出版信息
Antimicrob Agents Chemother. 1996 Jan;40(1):267-70. doi: 10.1128/AAC.40.1.267.
Abstract
We have developed a simple in vitro translation method to analyze compounds that inhibit the rhinovirus 3C protease in peptide substrate assays but demonstrate no antiviral activity. This complementary assay, which provides both qualitative and quantitative results, detects the inhibition of the 3CD protease in the native polyprotein form.
摘要
我们开发了一种简单的体外翻译方法，用于分析在肽底物测定中抑制鼻病毒3C蛋白酶但无抗病毒活性的化合物。这种补充测定法能提供定性和定量结果，可检测天然多蛋白形式的3CD蛋白酶的抑制情况。
相似文献
1
Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases.用于分析鼻病毒蛋白酶抑制剂的简单体外翻译试验。
Antimicrob Agents Chemother. 1996 Jan;40(1):267-70. doi: 10.1128/AAC.40.1.267.
2
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.人鼻病毒3C蛋白酶中氨基酸的保守性与新型人鼻病毒3C蛋白酶抑制剂鲁平替尼的广谱抗病毒活性相关。
Antimicrob Agents Chemother. 2005 Feb;49(2):619-26. doi: 10.1128/AAC.49.2.619-626.2005.
3
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.基于结构设计具有抗多种鼻病毒血清型的强效抗病毒活性的人鼻病毒3C蛋白酶的基于机制的不可逆抑制剂。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7. doi: 10.1073/pnas.96.20.11000.
4
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids.含N-甲基氨基酸的不可逆型三肽基人鼻病毒3C蛋白酶抑制剂的基于结构的设计
Bioorg Med Chem Lett. 1999 Aug 2;9(15):2189-94. doi: 10.1016/s0960-894x(99)00368-6.
5
Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.肽基溴甲基酮酰肼对人鼻病毒1B株3C蛋白酶的抑制作用
Arch Biochem Biophys. 1999 Feb 15;362(2):363-75. doi: 10.1006/abbi.1998.1038.
6
Development of in vitro peptide substrates for human rhinovirus-14 2A protease.人鼻病毒14型2A蛋白酶体外肽底物的开发
Arch Biochem Biophys. 1998 Aug 1;356(1):12-8. doi: 10.1006/abbi.1998.0746.
7
Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.弹性蛋白酶特异性抑制剂对脊髓灰质炎病毒和鼻病毒2A蛋白酶蛋白水解活性的抑制作用。
J Virol. 1993 Aug;67(8):4688-95. doi: 10.1128/JVI.67.8.4688-4695.1993.
8
Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing.肽基重氮甲基酮抑制人鼻病毒3C蛋白酶：通过部分阻断P3多蛋白加工对病毒产量的影响。
Antivir Chem Chemother. 2001 Sep;12(5):273-81. doi: 10.1177/095632020101200502.
9
Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.人鼻病毒14 3C蛋白酶对一系列合成肽底物的水解作用，该蛋白酶在大肠杆菌中克隆并表达。
J Gen Virol. 1989 Nov;70 ( Pt 11):2931-42. doi: 10.1099/0022-1317-70-11-2931.
10
Human rhinovirus 3C protease as a potential target for the development of antiviral agents.人鼻病毒3C蛋白酶作为抗病毒药物开发的潜在靶点。
Curr Protein Pept Sci. 2007 Feb;8(1):19-27. doi: 10.2174/138920307779941523.
引用本文的文献
1
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.人鼻病毒3C蛋白酶抑制剂AG7088对人鼻病毒诱导的细胞因子产生的抑制作用
Antimicrob Agents Chemother. 2000 May;44(5):1236-41. doi: 10.1128/AAC.44.5.1236-1241.2000.
2
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.人鼻病毒3C蛋白酶强效抑制剂AG7088的体外抗病毒活性
Antimicrob Agents Chemother. 1999 Oct;43(10):2444-50. doi: 10.1128/AAC.43.10.2444.
3
Protease inhibitors as antiviral agents.蛋白酶抑制剂作为抗病毒药物。
Clin Microbiol Rev. 1998 Oct;11(4):614-27. doi: 10.1128/CMR.11.4.614.
4
Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides.高邻苯二甲酰亚胺对人鼻病毒2A和3C蛋白酶的双重抑制作用。
Antimicrob Agents Chemother. 1998 Apr;42(4):916-20. doi: 10.1128/AAC.42.4.916.
5
The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition.甲型肝炎病毒3C基因产物的精细晶体结构：特异性蛋白酶活性和RNA识别
J Virol. 1997 Mar;71(3):2436-48. doi: 10.1128/JVI.71.3.2436-2448.1997.
本文引用的文献
1
Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli.在大肠杆菌中表达的重组人鼻病毒14 3C蛋白酶的纯化
Protein Expr Purif. 1995 Oct;6(5):609-18. doi: 10.1006/prep.1995.1080.
2
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.病毒编码蛋白酶的表达：与细胞酶的功能和结构相似性
Microbiol Rev. 1993 Dec;57(4):781-822. doi: 10.1128/mr.57.4.781-822.1993.
3
Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen.
J Antibiot (Tokyo). 1994 Jul;47(7):836-9. doi: 10.7164/antibiotics.47.836.
4
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.抗病毒化合物恩韦肟作用于鼻病毒和脊髓灰质炎病毒的3A编码区。
J Virol. 1995 Jul;69(7):4189-97. doi: 10.1128/JVI.69.7.4189-4197.1995.
5
A high capacity microbial screen for inhibitors of human rhinovirus protease 3C.一种用于筛选人鼻病毒3C蛋白酶抑制剂的高通量微生物筛选方法。
Biotechnology (N Y). 1994 Oct;12(10):1012-6. doi: 10.1038/nbt1094-1012.
6
Picornavirus inhibitors.小核糖核酸病毒抑制剂
Pharmacol Ther. 1994;64(2):215-90. doi: 10.1016/0163-7258(94)90040-x.
7
Fine-needle aspiration biopsy of the breast.乳房细针穿刺活检
Am Fam Physician. 1995 Nov 15;52(7):2021-5.
8
Proteolytic events in replication of animal viruses.
Ann N Y Acad Sci. 1980;343:304-18. doi: 10.1111/j.1749-6632.1980.tb47260.x.
9
In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase.体外分子遗传学作为一种确定脊髓灰质炎病毒3C蛋白酶差异切割特异性的工具。
Nucleic Acids Res. 1987 Mar 11;15(5):2069-88. doi: 10.1093/nar/15.5.2069.
10
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.用纯化的T7 RNA聚合酶合成传染性脊髓灰质炎病毒RNA
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2330-4. doi: 10.1073/pnas.83.8.2330.
Zotero 插件